SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-120986
Filing Date
2019-04-26
Accepted
2019-04-26 08:33:04
Documents
4
Period of Report
2019-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d724775d8k.htm 8-K 35942
2 EX-2.1 d724775dex21.htm EX-2.1 646991
3 EX-10.1 d724775dex101.htm EX-10.1 9156
4 EX-99.1 d724775dex991.htm EX-99.1 25321
  Complete submission text file 0001193125-19-120986.txt   718580
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35952 | Film No.: 19769467
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1